OpenMedicare
Start Here
Explore
Fraud
Investigations
Data
Tools
About

Footer

OpenMedicare

Independent Medicare data journalism

Sister Sites

  • OpenMedicaid
  • OpenFeds
  • OpenSpending

Explore

  • Providers
  • Procedures
  • States
  • Specialties
  • Search

Fraud Analysis

  • Still Out There (AI)
  • Fraud Overview
  • Fraud Watchlist
  • Deep Dive Profiles
  • Impossible Numbers
  • Report Fraud

Investigations

  • The Algorithm Knows
  • How We Built the Model
  • Internal Medicine Crisis
  • Florida & California Fraud
  • Million Dollar Flagged
  • All Investigations

Tools

  • Provider Lookup
  • Compare
  • Cost Calculator
  • Your Medicare Dollar
  • Downloads

About

  • About OpenMedicare
  • Methodology
  • Glossary
  • Data Sources
  • API Docs
  • Updates
Data Sources: Centers for Medicare & Medicaid Services (CMS), Medicare Provider Utilization and Payment Data
Disclaimer: This site is an independent journalism project. Data analysis and editorial content are not affiliated with or endorsed by CMS or any government agency. All spending figures are based on publicly available Medicare payment records.
Sister Sites: OpenMedicaid ยท OpenFeds ยท OpenSpending

ยฉ 2026 OpenMedicare. Independent data journalism. Built by TheDataProject.ai

Methodologyโ€ขDownload Data
  1. Home
  2. Providers
  3. Sl Consulting Llc
๐Ÿ”ฌ
Organization

Sl Consulting Llc

NPI: 1699162966
Las Vegas, NV
9 years of data
Clinical Laboratory
$12.1M
Total Payments
64.2K
Beneficiaries
195.7K
Services
3.53x
Markup Ratio

Peer Comparison

92th
percentile in specialty
This provider$12.1M
Specialty median$1.9M

๐Ÿ“‹ Key Findings

1Billed $12.1M over 9 years
23.53x markup ratio (above median)
392th percentile in Clinical Laboratory by payments
4Payments surged 4152% in 2016
57 procedures with >3x markup
โœ“ No flags detected

๐Ÿ”Ž Data Analysis

This provider's $12.1M in total Medicare payments ranks in the 92th percentile of Clinical Laboratory providers nationally.

Medicare payments to this provider grew 9734% from 2015 to 2023.

AI-generated analysis based on Medicare payment data.

Annual Medicare Payments

Annual Services Provided

Avg Payment per Service

Markup Ratio Over Time

๐Ÿ“ˆ

Notable: Payments increased 4152% in 2016

Year-over-year payment surges can indicate changes in practice volume, new services, or billing pattern shifts.

Submitted Charges vs. Medicare Payments

Average per-service amounts submitted by the provider compared to what Medicare actually paid โ€” the gap represents the markup.

YearAvg SubmittedAvg PaidMarkup RatioGap per ServiceTotal PaymentsServicesBeneficiaries
2015$59.77$24.342.46x$35.43$15.5K678625
2016$170.64$50.193.40x$120.45$661.2K8.4K4.8K
2017$315.76$96.003.29x$219.76$719.0K5.1K2.9K
2018$314.72$101.313.11x$213.41$490.2K3.9K2.3K
2019$201.38$52.923.81x$148.46$976.4K9.4K4.5K
2020$219.34$65.793.33x$153.55$1.8M26.7K12.1K
2021$236.01$71.053.32x$164.96$2.4M43.4K14.4K
2022$139.24$41.683.34x$97.56$3.5M64.1K10.5K
2023$86.20$28.233.05x$57.97$1.5M34.0K12.0K

Top Procedures (20)

U00042019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-rโš  4.0x markup
$3.2M
42.0K services$75.34/svc3.98x markup
G0483Drug test def 22+ classesโš  4.0x markup
$2.9M
12.4K services$238.68/svc4.02x markup
U0005Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed withinโš  3.0x markup
$979.0K
39.7K services$24.68/svc3.04x markup
87631Detection test for multiple types of respiratory virus
$951.9K
6.7K services$142.11/svc2.23x markup
80307Testing for presence of drugโš  4.8x markup
$880.4K
13.3K services$65.97/svc4.80x markup
G0480Drug test(s), definitive, utilizing drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (anโš  3.9x markup
$425.6K
3.8K services$112.12/svc3.93x markup
G0482Drug test def 15-21 classesโš  3.4x markup
$313.5K
1.6K services$195.79/svc3.37x markup
87798Detection test for organism
$300.8K
8.6K services$34.94/svc2.48x markup
87486Detection test for chlamydia pneumoniae
$258.9K
7.4K services$35.01/svc2.47x markup
87581Detection test for mycoplasma pneumoniae (bacteria)
$258.9K
7.4K services$35.01/svc2.47x markup
87541Detection test for legionella pneumophila (water borne bacteria)
$258.8K
7.4K services$35.01/svc2.47x markup
87640Detection test for staphylococcus aureus (bacteria)
$182.9K
5.2K services$35.08/svc2.47x markup
87532Detection test for herpes virus-6
$182.9K
5.2K services$35.08/svc2.47x markup
87496Detection test for cytomegalovirus (cmv)
$182.8K
5.2K services$35.08/svc2.47x markup
G0481Drug test def 8-14 classes
$178.3K
1.2K services$154.68/svc2.13x markup
G0479Drug tests(s), presumptive, any number of drug classes; any number of devices or procedures by instrumented chemistry analyzers utilizing immunoassay, enzyme assay, TOF, MALDI, LDTD, DESI, DART, GHPC, GC mass spectrometry), includes sample validation whenโš  3.5x markup
$163.9K
2.1K services$77.56/svc3.54x markup
87635Sars-cov-2 covid-19 amp prb
$102.8K
2.0K services$51.31/svc2.05x markup
87481Detection test for candida species (yeast)
$48.9K
1.4K services$34.70/svc2.49x markup
87653Detection test for strep (streptococcus, group b)
$48.4K
1.4K services$34.70/svc2.49x markup
U00022019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc
$32.7K
651 services$50.28/svc2.19x markup
Show detailed table โ–พ
CodeDescriptionServicesPaymentsAvg/ServiceMarkup
U00042019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r42.0K$3.2M$75.343.98x
G0483Drug test def 22+ classes12.4K$2.9M$238.684.02x
U0005Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within39.7K$979.0K$24.683.04x
87631Detection test for multiple types of respiratory virus6.7K$951.9K$142.112.23x
80307Testing for presence of drug13.3K$880.4K$65.974.80x
G0480Drug test(s), definitive, utilizing drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (an3.8K$425.6K$112.123.93x
G0482Drug test def 15-21 classes1.6K$313.5K$195.793.37x
87798Detection test for organism8.6K$300.8K$34.942.48x
87486Detection test for chlamydia pneumoniae7.4K$258.9K$35.012.47x
87581Detection test for mycoplasma pneumoniae (bacteria)7.4K$258.9K$35.012.47x
87541Detection test for legionella pneumophila (water borne bacteria)7.4K$258.8K$35.012.47x
87640Detection test for staphylococcus aureus (bacteria)5.2K$182.9K$35.082.47x
87532Detection test for herpes virus-65.2K$182.9K$35.082.47x
87496Detection test for cytomegalovirus (cmv)5.2K$182.8K$35.082.47x
G0481Drug test def 8-14 classes1.2K$178.3K$154.682.13x
G0479Drug tests(s), presumptive, any number of drug classes; any number of devices or procedures by instrumented chemistry analyzers utilizing immunoassay, enzyme assay, TOF, MALDI, LDTD, DESI, DART, GHPC, GC mass spectrometry), includes sample validation when2.1K$163.9K$77.563.54x
87635Sars-cov-2 covid-19 amp prb2.0K$102.8K$51.312.05x
87481Detection test for candida species (yeast)1.4K$48.9K$34.702.49x
87653Detection test for strep (streptococcus, group b)1.4K$48.4K$34.702.49x
U00022019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc651$32.7K$50.282.19x

Markup Analysis

Charge-to-Payment Ratio

3.53x

This provider submits charges 3.53 times higher than what Medicare actually pays.

What This Means

A markup ratio of 3.53x means for every $100 Medicare pays, this provider initially charges $353. This is higher than the national average.

Location

Las Vegas, NV

Provider Verification

Always verify provider credentials and location before scheduling appointments. This data reflects Medicare payments and may not include all practice locations.

Similar Providers

Other Clinical Laboratory providers in NV for peer comparison.

Sl Consulting Llc (you)
$12.1M
Quest Diagnostics Incorporatedโš ๏ธ
$182.1M
Md Spine Solutions Llc
$79.7M
Show detailed table โ–พ
ProviderLocationTotal PaymentsStatus
Quest Diagnostics IncorporatedLas Vegas, NV$182.1Mโš ๏ธ Flagged
Md Spine Solutions LlcReno, NV$79.7Mโœ“ Clear

Related

Browse
โ† Back to Provider Directory
State
All providers in NV โ†’
Specialty
All Clinical Laboratory providers โ†’
Tool
Compare this provider โ†’
Analysis
Fraud Watchlist โ†’
Search
Search all providers โ†’

Share This Provider

Share this provider's Medicare payment information

Share:

Data Sources

  • โ€ข Centers for Medicare & Medicaid Services (CMS)
  • โ€ข Medicare Provider Utilization and Payment Data (2014-2023)
  • โ€ข National Plan and Provider Enumeration System (NPPES)

Last Updated: February 2026 (data through 2023, the latest CMS release)

Note: All data is from publicly available Medicare records. OpenMedicare is an independent journalism project not affiliated with CMS.

Believe this data is inaccurate? Dispute this data